SCHEMBL15969664

SCHEMBL15969664

COC(=O)c1ccc(CN(C2CCCCC2)S(=O)(=O)c2ccc(Cl)cc2)cc1.O=C(O)c1ccc(CN(C2CCCCC2)S(=O)(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
NPSR1 Q6W5P4 1/20 0.59
KDM4E B2RXH2 1/20 0.53
HSD17B10 Q99714 1/20 0.53
PSEN1 P49768 7/20 0.52
PSEN2 P49810 7/20 0.52
APH1B Q8WW43 7/20 0.52
NCSTN Q92542 7/20 0.52
APH1A Q96BI3 7/20 0.52
PSENEN Q9NZ42 7/20 0.52
AVPR1B P47901 1/20 0.52
TAS2R14 Q9NYV8 4/20 0.52
PTGES O14684 1/20 0.52
CXCR3 P49682 1/20 0.51
CNR1 P21554 2/20 0.51
CNR2 P34972 2/20 0.51
MAPT P10636 1/20 0.50
THRB P10828 1/20 0.49
USP2 O75604 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14842995 0.96 MEN1 (0.60) MEN1KMT2ANPSR1KDM4EHSD17B10
SCHEMBL14842203 0.92 MEN1 (0.79) MEN1KMT2ANPSR1PSEN1PSEN2
SCHEMBL14842485 0.86 MEN1 (0.48) MEN1KMT2AKDM4EHSD17B10PSEN1
SCHEMBL14842437 0.86 HDAC8 (0.50) MEN1KMT2AKDM4EHSD17B10PSEN1
SCHEMBL14842844 0.85 MEN1 (0.76) MEN1KMT2ANPSR1KDM4EHSD17B10
SCHEMBL5568933 0.85 PSEN1 (0.75) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8363839 0.84 PSEN1 (0.51) MEN1KMT2AKDM4EHSD17B10PSEN1
SCHEMBL15981121 0.83 MEN1 (0.48) MEN1KMT2AKDM4EHSD17B10PSEN1
SCHEMBL8363935 0.83 MEN1 (0.46) MEN1KMT2AKDM4EHSD17B10PSEN1
SCHEMBL26159101 0.83 PTGES (0.68) MEN1KMT2ANPSR1PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140243374-A1 Novel Sulfonamides BRIGHAM & WOMENS HOSPITAL (US) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243374-A1 Novel Sulfonamides BACE1, BACE2, GSAP MEN1 2751/4885KMT2A 1573/4885NPSR1 858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.